DexCom, Inc. (DXCM) vs Medtronic PLC (MDT)
- DexCom, Inc. DXCM 79.73 −5.60%
- Medtronic PLC MDT 102.05 −2.66%
DexCom, Inc. and Medtronic PLC are both Medical Devices companies. Medtronic PLC is the larger, with a market value of $134.1B against $31.5B — 4.3× the size. Medtronic PLC trades at the lower P/E: 25.6× against 32.6×. DexCom, Inc. grew revenue faster over the last twelve months: 13.0% against 9.77%. DexCom, Inc. has the higher net margin (19.4% vs 13.9%) and the higher return on invested capital (39.0% vs 6.04%). Across the 22 metrics below, DexCom, Inc. leads on 12 and Medtronic PLC on 10.
Valuation
Profitability
| Metric | DXCM | MDT | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.42% | 65.01% | 57.76% |
| Operating margin | 23.98% | 18.08% | (15.07%) |
| Net margin | 19.41% | 13.93% | (14.45%) |
| Free cash flow margin | 21.52% | 16.33% | (3.88%) |
| Return on equity | 37.67% | 10.57% | (10.35%) |
| Return on assets | 14.43% | 5.68% | (17.26%) |
| Return on invested capital | 39.00% | 6.04% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack